Showing 6191-6200 of 9993 results for "".
- Zubin Meshginpoosh Named President and COO at Sentéhttps://practicaldermatology.com/news/zubin-meshginpoosh-named-president-and-coo-at-sente/2461463/Zubin Meshginpoosh is now the President and Chief Operational Officer of Senté. "Zubin has an incredible track record for enabling teams to achieve success in high growth and fast-changing environments," says Faheem Hasnain, Chairman of the Board at Senté, in a n
- New Melanoma Immunotherapy Drugs Are Saving Liveshttps://practicaldermatology.com/news/new-melanoma-immunotherapy-drugs-are-saving-lives/2461462/New research suggest that the use of new pharmacological therapies is associated with a decrease in the melanoma mortality rate in the U.S. population. In the population-based cross-sectional study of patients with cutaneous melanoma from the Surveillance, Epidemiology, and E
- UCB’s Bimekizumab Performs Well in PsA Studieshttps://practicaldermatology.com/news/ucbs-bimekizumab-performs-well-in-psa-studies/2461460/Two new studies highlight the efficacy and safety of bimekizumab in the treatment of adults with active psoriatic arthritis who were biologic-naïve and/or tumor necrosis factor inhibitor inadequate responders (TNFi-IR). The 24-week results from the Phase 3 BE OPTIMAL study and 16-w
- American Hair Research Society to Host Hybrid Alopecia Areata Summit 12/10-11https://practicaldermatology.com/news/american-hair-research-society-to-host-hybrid-alopecia-areata-summit-1210-11/2461459/The Alopecia Areata Summit “New Pathways, New Treatments” organized by the American Hair Research Society will be held December 10-11 at the New York Academy of Medicine, 1216 5th Ave., New York, NY. The meeting is being co-Chaired by Angela M. Christiano, PhD, Columbia Univ
- Arcutis Enrolls First Patient in Phase 1b Alopecia Areata Study of ARQ-255https://practicaldermatology.com/news/arcutis-enrolls-first-patient-in-phase-1b-alopecia-areata-study-of-arq-255/2461458/The first subject has been enrolled in a Phase 1b study evaluating Arcutis’ ARQ-255, a topical suspension of ivarmactinib, a potent and specific janus kinase 1 (JAK1) inhibitor, for the treatment of alopecia areata. ARQ-255 has been specifically formulated with Arcutis’
- Cosmetic Surgery Forum 2022 Kicks Off in Nashvillehttps://practicaldermatology.com/news/cosmetic-surgery-forum-2022-kicks-off-in-nashville/2461451/Now in its 14th year, the 2022 Cosmetic Surgery Forum is once again taking Nashville by storm with new faculty members, a new roundtable, and exciting new topics along with the frank discussions, candor, and live demos that attendees have come to expect. “CSF 2022 is our be
- Wireless Smart Bandage May Speed Wound Healinghttps://practicaldermatology.com/news/wireless-smart-bandage-may-speed-wound-healing/2461444/A new wireless smart bandage may speed up tissue repair by monitoring the wound healing process and treating the wound simultaneously, according to research in Nature Biotechnology. The device promotes faster closure of wounds, increases new blood flow to injured tissue, and enhanc
- Laser Could Prevent UV Radiation-Induced Damage to Skinhttps://practicaldermatology.com/news/laser-could-prevent-uv-radiation-induced-damage-to-skin/2461438/Incidence rates of squamous cell carcinomas (SCCs) are increasing, particularly in high-risk populations, including fair-skinned or immunosuppressed individuals. Few therapeutic options exist to prevent sunlight-induced skin cancer despite rising incidence rates. A recent study determined that ab
- CeraVe Establishes Fund at Howard University to Address Lack of Diversity in Skincare Clinical Researchhttps://practicaldermatology.com/news/cerave-establishes-fund-at-howard-university-to-address-lack-of-diversity-in-skincare-clinical-research/2461435/To help close the existing racial inequity gap in dermatological research, CeraVe is establishing a fund at Howard University to help its faculty further their expertise and build the infrastructure needed to conduct clinical trials with a focus on skin of color. Located in Washing
- Merz Aesthetics Now Offering the SaltFacial by SaltMEDhttps://practicaldermatology.com/news/merz-aesthetics-now-offering-the-saltfacial-by-saltmed/2461433/Merz Aesthetics and SaltMED are extending their commercial agreement adding The SaltFacial by SaltMED to the portfolio of products offered by Merz Aesthetics. The SaltFacial is a skin rejuvenation system that targets the texture, tone ,and color of skin.